第一单位：
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
作者：
Matthew J,Rees [1]
;
Jack,Khouri [2]
;
Ariel F,Grajales-Cruz [3]
;
Saurabh S,Zanwar [1]
;
Utkarsh,Goel [2]
;
Shonali,Midha [4]
;
Julian,Kelley [5]
;
Omar Castaneda,Puglianini [3]
;
Andre De Menezes Silva,Corraes [1]
;
Shahzad,Raza [2]
;
James A,Davis [6]
;
Kimberly,Green [6]
;
Doris K,Hansen [3]
;
Rahul,Banerjee [7]
;
Surbhi,Sidana [8]
;
Krina K,Patel [9]
;
Giada,Bianchi [10]
;
Douglas W,Sborov [5]
;
Sarah,Lee [11]
;
Shaji K,Kumar [1]
;
Rachid,Baz [3]
;
Faiz,Anwer [2]
;
Lekha,Mikkilineni [8]
;
Omar,Nadeem [4]
;
Yi,Lin [1]
;
Larry D,Anderson [12]
作者单位：
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
[1]
Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
[2]
Moffitt Cancer Center, Tampa, Florida, USA.
[3]
Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[4]
Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA.
[5]
Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.
[6]
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
[7]
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California, USA.
[8]
MD Anderson Cancer Center, Houston, Texas, USA.
[9]
Amyloidosis Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[10]
Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, California, USA.
[11]
Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
[12]
DOI
10.1002/ajh.70140
PMID
41221958
发布时间
2025-12-02
换一批
